Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.

NIB (ASX:NHF) and Medibank (ASX:MPL) Report Record-Low Premium Increases – Is It Time To Buy Sell?

NIB Holdings Limited (ASX:NHF) and Medibank Private Limited (ASX:MPL) have both reported their lowest premium increases in many years.

NIB Holdings Limited (ASX: NHF) and Medibank Private Limited (ASX: MPL) have reported their lowest level of insurance premium increases in many years.

NIB Holdings and Medibank Private are two of Australia’s largest private health insurers. Medibank operates the low-cost ahm brand, whilst NIB operates the corporate health insurer GU Health Insurance.

Approved premium increases

The Federal Minister for Health has approved NIB to increase its insurance premiums by an average of 3.38% across all of its products. GU Health Insurance premiums will increase by an average of 1.8%.

The NIB increase is the lowest for 16 years. It also said it will implement reforms of including an introduction of discounts for members under the age of 30, classifying products into easy to understand tiers and offering the choice of a higher hospital excess for members.

NIB Managing Director Mark Fitzgibbon talked up his company’s efforts to make health insurance more affordable:

This is the fifth consecutive year we’ve been able to deliver an average premium change lower than the previous year reflecting our ongoing focus on cost containment and inflation.”

Meanwhile, Medibank said that Medibank and ahm premiums will increase by an average of 3.3%, which is the lowest increase in 18 years. Medibank also confirmed it is implementing the reforms.

To make up for the slow premium rises, Medibank is aiming to cut $60 million of costs to the end of FY20.

Is it Time to Buy Shares In Private Health Insurers?

In early trading today, the Medibank share price is up nearly 3% according to Google Finance, whilst NIB’s shares are up 0.6%.

I think Medibank’s CEO Craig Drummond may have said it best in the press release when he said: “The challenge remains, as to how we can continue to deliver quality healthcare in Australia, at an affordable price.”

Until the private health affordability issue is resolved it’s likely that policyholder growth will be low for Medibank and NIB, if not negative. For example, Australian wage growth is less than the premium rises each year, making it even harder for households to justify.

It could be a better move to pick healthcare shares that are creating growth regardless of the difficulty in private health affordability, such as the two growth shares outlined in the free report below.

[ls_content_block id=”14947″ para=”paragraphs”]

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

Skip to content